Introduction
Gene transfer into hematopoietic stem/progenitor cells (HSC) by gammaretroviral vectors has been demonstrated an effective treatment for inherited blood disorders, including X-linked severe combined immunodeficiency (X1-SCID) 1, 2 , adenosine deaminase-deficient SCID (ADA-SCID) 3 and X-linked
Chronic Granulomatous Disease (X-CGD) 4 . However, following the occurrence of leukemic proliferation in 5 out of 19 SCID-X1 patients 5, 6 and of clonal expansion in 2 CGD patients 7 , the safety of the use of retroviral vectors turned out to be a primary concern. Since the viral RNA genome is reverse transcribed into a DNA copy that becomes integrated into the host cell genome, RV may induce cell transformation by insertional mutagenesis leading to proto-oncogene trans-activation, in combination to transgene-and diseasespecific co-factors.
The genomic features driving the preferential integration of retroviral vectors have been described in several large-scale survey of mapping studies in mice, non-human primates and humans enrolled in clinical trials [8] [9] [10] [11] [12] [13] [14] .
These studies have shown that RV integrate non-randomly in the host genome favoring transcription start sites and expressed genes, which makes productive interactions between the vector and host transcriptional machinery more likely. As a result of this bias, integrations which alter the expression of flanking genes involved in cell cycle, transcriptional activity, and signal transduction, might influence the biological fate of the affected cell clone, thereby conferring a growth or survival advantage 4, 15, 16 . However, to gain relevant information on the influence of vector integrations on transcriptional activity of nearby genes, studies should be carried out in relevant primary cells at the level of a clonal population containing defined insertion sites.
Previous work conducted in the context of gene therapy with retrovirally transduced peripheral blood T cells revealed that RV insertion induced over-expression of a proximal gene at a frequency of almost 20%, although without measurable consequences on the biology and function of infused cells 17 .
We showed previously that promoters and transcriptionally active genes are preferential sites of RV integration also in BM-derived, transduced CD34 + progenitor cells, and in their progeny isolated ex vivo from ADA-SCID patients. We also found that, in an ADA-deficient context, selective growth advantage of ADA + lymphocytes is associated with a significant bias towards integrations in genomic regions allowing a sustained transgene expression. Nevertheless, infusion of ADA-transduced HSCs is safe long-term and does not result in in vivo clonal expansion or malignant transformation up to 8 years after treatment 11, 18 .
For personal use only. on September 13, 2017 . by guest www.bloodjournal.org From caused by vector integration, in both bulk populations and single clones of transduced T cells. Our data show that RV integration induce minor changes in the transcriptional activity of nearby endogenous genes at clonal level, which, however, does not impact on the biology of the T-cell clones. In addition, they provide crucial information for the development of future gene therapy protocols.
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Methods

Patients
The ADA-SCID GT clinical trial was approved by the San Raffaele Scientific Institute and Hadassah University Ethical Committees and the respective National Regulatory authorities. The clinical trials are registered at ClinicalTrials.gov (numbers NCT00598481 and NCT00599781). The patients' characteristics and treatment have been described previously 3, 11 . Under these conditions, cloning efficiencies were 1.2% for Pt2, 1.9% for Pt3, and 5.1% for healthy donor. Tcell clones were expanded by adding fresh medium with 600IU/ml rhIL-2 and restimulated as described every 14 days. The generation of T-cell clones at sufficient numbers for performing experiments required 4 cycles of restimulation. Phenotypic analysis, qRT-PCR, biochemical and functional assays were performed in resting T-cell clones sampled following 4-6 cycles at day 14 after restimulation.
Analysis of T-cell phenotype and function
Anti-CD4, -CD8, -TCRαβ, -TCRγδ mAbs directly coupled with FITC or PE were from BD Bioscience.
Expression of ADA protein was assessed by intracellular staining using an anti-human ADA mAb, as 
Analysis of RV integration sites
Genomic DNA was extracted from T-cell clones using QIAamp DNA Blood Mini kit (Qiagen Inc., USA).
Inverse-PCR was performed as previously described 11 . The resultant nested PCR products were either separated on 2% agarose excised and directly sequenced. Integration were mapped onto human genome by BLAST analysis using the ENSEMBL search engine (November 2004 freeze).
Quantitative tracking of specific integrants
Quantitative PCR analysis was performed on 50 ng genomic DNA, directly isolated from sorted CD3 + T cells, using the specific genomic flanking primers in combination with common LTR primer and probe (Primm, Italy). The primer sequence were as follows: 3'LTR primer, 5'-GTTTGCATCCGAATCGTGGT- Using a supervised hierarchical ordering approach, one-way analysis of variance was performed to search for genes which varied significantly between patients' and control samples. We identified as low as 235 (2.5%) genes, among the CD4 + dataset, and 479 (5.1%) genes, among the CD8 + dataset, differentially expressed in the cluster of patients as compared to that of controls ( Fig. 1C-D) . However, when we applied a multiple testing corrections with the least stringent Benjamini and Hochberg False Discovery Rate procedure, no significant differences were observed in the gene expression patterns between the two groups (not shown).
Such findings are in keeping with the lack of sample segregation according to the treatment, as observed by the clustering analysis.
These results indicate that our GT protocol causes no major alterations in the gene expression program of T lymphocytes developed from genetically-corrected CD34 + cells.
Analysis of retroviral vector integrations and diversity of T-cell clones.
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To study the effect of vector integration on gene expression and cell function at clonal level, primary T-cell clones were isolated ex vivo by limiting dilution from PB lymphocytes of two ADA-SCID patients 18 months after GT 11 (Pt2 (X), 26 clones; Pt3 (Y), 27 clones). Among the clones generated from Pt2, four Phenotypically, all clones were CD4 + T cells and displayed a high diversity in the T-cell receptor (TCR) β chain usage (Fig. 3A) , mirroring the complexity of the immune reconstitution occurred in patients. To track the in vivo origin of T-cell clones, we combined the RIS mapping with TCR Vβ analysis. In 5 cases we could identify T-cell clones harboring distinct Vβ TCR that shared the same vector insertion, indicating that they derived from the same pre-thymic progenitor ( Fig. 3B and Suppl. Table 1 ). Interestingly, RIS identified in multiple cell clones (i.e. ID-04 and ID-16 found in five and three clones, respectively) are present at relatively higher frequency within the ex vivo isolated CD3 + population, thus demonstrating that RIS sampled in the T-cell clones are directly representative of the in vivo clonal composition at the time of cloning. Moreover, some of these T-cell clones shared the same RIS previously identified in CD15 + granulocytes and CD19 + B lymphocytes in the same patients 11 , confirming their common origin from transduced multipotent HSCs (Fig. 3D ).
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We next investigated any potential transcriptional perturbation of the genes surrounding RIS in prospectively isolated ex vivo T-cell clones. Adequate RNA material was available for 43 clones, corresponding to 35 different RV insertion sites. We studied the expression level of all genes contained in an interval of 200 kb centered on the site of RV integration. This broad interval was chosen because previous studies have suggested that insertional gene activation is not merely a function of the distance of the RV from the TSSs 16, 17 . Overall, we analyzed a total of 120 different genes (T-cell clone gene-set). The transcriptional profile of the T-cell clone gene-set was preliminary evaluated within the Affymetrix datasets of purified T cells from HD, to assess their relative expression with respect to the global average transcription levels. The proportion of expressed genes in the array did not increase significantly when the analysis was restricted to genes landed within 100 kb from RIS (43.3% vs 44.9%; Suppl. Figure 1A ), indicating that no bias towards expressed genes was introduced with the chosen cut-off. Functional classification indicated that RV hit genes belonged to major networks involved in cellular process and metabolism groups, and without any particular skewing with respect to the expected distribution (Suppl. Fig   1B) . Three genes (2.5%) are known proto-oncogenes, of which one (BLM) was identified as common insertion site (CIS) in our previously published collection 11 .
Using custom Taqman Low Density Arrays (LDA), the expression of the genes hit by the vector was evaluated in the clone(s) in which the integration was identified and compared to the level of expression found in the other clones carrying integrations in different loci. Untransduced (UT) clones from Pt2 (n=4) as well as clones from healthy donors (HD, n=3) were used as additional controls. Normalized expression levels of genes neighbouring RV insertion sites are represented in Figure 4A -B. Since normal distribution of data was doubtful and normal approximations to obtain standard errors and confidence intervals cannot be correctly used, we employed a non-parametric permutation test based on re-sampling, which shifts the assignment of sample within each single RIS and re-computes the t statistic each time.
This analysis revealed that 7 out of the 120 genes assayed (5.8%) had a significantly perturbed expression in the clones carrying a RV integration at a distance of <100 kb (Table 2 and Suppl. . Fig 1 and data not shown) .
To compare the genotoxic potential of RV vector insertion in T-cells in the absence of in vivo selection, we used the same quantitative assay and analysis criteria to re-analyzed perturbation of gene expression around RV insertion site in T-cell clones from one of our previous studies 17 . By this analysis, 6/29 (20.7%) randomly selected clones showed significantly higher expression in 6/68 (8.8%) genes close to an integrated provirus. In non transplanted T-cells, activating RIS increased mRNA transcript level at a similar frequency but in a more prominent fashion, ranging from 3.2-fold (ZNF217) to more than 1,900-fold (LY64) the average value in the control clones ( Fig. 4C and Suppl. Table 3 ). Deregulation of gene expression occurred preferentially when a provirus was integrated in close proximity of a TSS (≤50 kb; Suppl. Fig. 2 ) and in opposite transcriptional orientation, in both ex vivo and in vitro clones.
RIS-associated altered gene expression has no impact on phenotype and functional behavior of T-cell clones.
To evaluate the consequences of vector integration on the biology of T-cell clones, we first asked whether perturbation in neighboring gene transcription could influence the ADA transgene expression. ADA transcript analysis was measured with LDA in (i) clones carrying deregulating RIS (n=6), (ii) other transduced clones (n=37), (iii) untransduced clones from ADA-SCID patients (n=4) and (iv) control clones from healthy subjects (n=3) (Fig.5A) . Relative ADA mRNA level was significantly lower in untransduced clones when compared to transduced and normal clones (p=0.023), whereas no difference in ADA expression was observed between the last two groups. Interestingly, clones with two proviruses generally showed higher ADA mRNA levels with respect to clones carrying one provirus, and closer to normal levels.
Remarkably, deregulating RIS had no discernible effect on transgene expression in all the hit clones with the exception of clone Y7, which harbored two integration events (Fig.5A) . Similar results were achieved when
was observed between the protein expression and the vector copy number, since only clones carrying two proviruses restored ADA to normal levels (p=0.036, Fig. 5B) . A significant tendency to select for integrations in genomic regions potentially more favorable to vector-derived ADA expression has been previously reported for ex vivo purified bulk T cells 11 . This tendency was further enhanced in in vitro expanded clones (Table 1) . The ability to produce both Th1 and Th2-like cytokines was also restored to normal level (Fig. 5D) . Finally, it is worth noting that cell clones displaying significantly dysregulated gene expression did not show increased basal proliferation or aberrant functional responses upon mitogen stimulation.
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We took advantage of the availability of untransduced, gene-corrected and normal T-cell clones to study at single cell level the effect of restored ADA expression on other enzymes involved in purine metabolism (Fig.   6A ). Indeed, in the absence of ADA, increased amounts of adenosine (Ado) and deoxy-adenosine (dAdo) may "spill over" into additional intracellular metabolic pathways normally only minimally utilized [22] [23] [24] , thus contributing to the pathogenetic mechanisms of the disease.
First, we focused on S-Adenosylhomocysteine Hydrolase (SAHH) enzyme, as reduction of its activity has been extensively documented in cells from ADA-SCID patients and considered an hallmark of the disease 19,25 . Whereas no difference in the relative mRNA expression was detected between untransduced and genecorrected or normal clones (Fig. 6B) , a marked block in SAHH activity was observed in untransduced clones (p=0.029 vs gene-corrected clones, p=0.012 vs normal clones; Fig.6C ). In contrast, normalization of SAHH activity was detected in gene-corrected cells (Fig. 6C ). Of note, T-cell clones carrying two proviruses showed the best recovery of enzyme function, in keeping with the highest expression of ADA protein (Fig.   6C ).
Although dAdo is a weak substrate for Adenosine Kinase (AK) and Deoxycytidine Kinase (DCK), in the absence of ADA these enzymes can phosphorylate dAdo. In turn, the resulting dATP pool expansion may interfere with a number of metabolic pathways critically required for cell viability 26 . Similarly, Ado phosphorylation-induced pyrimidine depletion has been one of the first mechanism proposed as the cause of lymphopenia in ADA deficiency 27 .
Remarkably, expression analysis in our cohort of T-cell clones revealed that mRNA transcript levels of both kinases were significantly upregulated (2 and 2.6 fold increase for DCK and AK, respectively; Fig suggest that these clones do not represent a major fraction of the cell populations tested.
In summary, beside the actual risk for RV-mediated perturbation in the host cellular transcriptional activity, these results indicate that GT for ADA-SCID retains a low risk profile and that disease-specific co-factors need to be accounted in future designing of clinical trial 33,36-38 .
In this regard, the construction of so-called self-inactivating (SIN) vectors should allow to further reduce the risk of insertional gene activation [39] [40] [41] . Different approaches would be to incorporate suicide genes in therapeutic vector 42 , or insulators 43 . However, the impact of such modifications on vector safety remains speculative and it has to be demonstrated in appropriate pre-clinical models.
For personal use only. on September 13, 2017 . by guest www.bloodjournal.org From This restriction tested 9.364 genes. About 468,2 genes would be expected to pass the restriction by chance. Table 1 . RIS distribution in T-cell clones from ADA-SCID patients. Distribution of RV integration sites mapped in T-cell clones isolated ex vivo from the peripheral blood of Pt2 and Pt3 at 18 months after gene therapy, compared to RV integrations in pre-GT and post-GT bulk samples from a previously published collection (Aiuti et al., 2007) . Integrations were distributed as inside (intragenic) or outside (intergenic) RefSeq genes, and at a distance of <10 kb upstream or ± 5 kb from TSSs. Table 2 . Genes with deregulated expression induced by the nearby RIS. List of genes displaying altered mRNA level in the ex vivo isolated T-cell clone(s) harbouring RIS. T-cell clones retrieved from Pt2 are indicated with X, clones from Pt3 with Y. Vector orientation is relative to targeted gene transcription. Relative gene expression level is indicated as normalized for the housekeeping gene (GAPDH) in each hit clone, and as fold change relative to the calibrator, as described in Methods. n.a., not applicable.
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